DOKA Stock Analysis: Dorma Kaba Holding | SW
Building Products & Equipment | SW, Switzerland | Market Cap: 2.587m CHF | 12M Return: -12.5% | CH1486524122 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.13M
Rev. Trend: -22.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
dormakaba Holding AG is a Swiss-headquartered provider of access and security solutions, offering a broad portfolio that spans door hardware, interior glass systems, automatic entrance systems, mechanical and electronic key systems, lodging access management, and safe locks. The company serves a wide range of end markets, including airports, healthcare, hospitality, multihousing, office, residential, and utilities, and was founded in 1862 with its headquarters in Rümlang, Switzerland.
The business model is built on integrated access solutions rather than standalone products, combining mechanical hardware with electronic access control, data systems, and software-enabled services such as time and attendance, mobile access, and touch-free entry. The physical access industry in which dormakaba operates sits at the intersection of building products, security, and increasingly information technology, as digital credentials, biometric readers, and IoT-connected door systems are gradually replacing purely mechanical locking mechanisms.
The company markets its safe locks under several well-known brands, including LA GARD, Mauer, Cencon, Paxos, and Auditcon, reflecting a portfolio assembled through decades of acquisitions in the global locks and access control market. It also offers solutions tailored to specific customer needs, such as fire protection, accessibility compliance, hygiene and infection prevention, and people flow management, positioning the company as a one-stop supplier for commercial and institutional building security infrastructure.
- Hospitality recovery boosts lodging systems revenue
- Commercial construction drives entrance systems demand
- Assa Abloy competition
| Net Income: 97.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.64 > 1.0 |
| NWC/Revenue: 17.67% < 20% (prev 16.32%; Δ 1.35% < -1%) |
| CFO/TA 0.15 > 3% & CFO 289.7m > Net Income 97.0m |
| Net Debt (356.7m) to EBITDA (464.0m): 0.77 < 3 |
| Current Ratio: 1.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.1m) vs 12m ago 894.0% < -2% |
| Gross Margin: 41.38% > 18% (prev 40.95%; Δ 0.43% > 0.5%) |
| Asset Turnover: 134.0% > 50% (prev 132.0%; Δ 2.04% > 0%) |
| Interest Coverage Ratio: 9.03 > 6 (EBIT TTM 354.8m / Interest Expense TTM 39.3m) |
| A: 0.25 (Total Current Assets 1.21b - Total Current Liabilities 714.1m) / Total Assets 1.99b |
| B: -0.18 (Retained Earnings -356.3m / Total Assets 1.99b) |
| C: 0.17 (EBIT TTM 354.8m / Avg Total Assets 2.08b) |
| D: 0.23 (Book Value of Equity 340.2m / Total Liabilities 1.47b) |
| Altman-Z'' = 2.43 = A |
| DSRI: 1.20 (Receivables 550.1m/470.5m, Revenue 2.79b/2.87b) |
| GMI: 0.99 (GM 40.95% / 41.38%) |
| AQI: 1.34 (AQ_t 0.19 / AQ_t-1 0.14) |
| SGI: 0.97 (Revenue 2.79b / 2.87b) |
| TATA: -0.10 (NI 97.0m - CFO 289.7m) / TA 1.99b) |
| Beneish M = -2.70 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at CHF 61.30 with a total of 47,196 shares traded. Over the past week, the price has changed by -1.29%, over one month by +5.51%, over three months by +15.44% and over the past year by -12.50%.
Current recommended Stop Loss: 58.90 (which is 3.9% or 1.3 ATR below the current price).
Dorma Kaba Holding has no consensus analysts rating.
P/E Trailing = 27.0435
P/E Forward = 11.4679
P/S = 0.9264
P/B = 7.5427
P/EG = 3.5606
Revenue TTM = 2.79b CHF
EBIT TTM = 354.8m CHF
EBITDA TTM = 464.0m CHF
Long Term Debt = 478.5m CHF (from longTermDebt, last quarter)
Short Term Debt = 23.5m CHF (from shortTermDebt, last quarter)
Debt = 505.8m CHF (from shortLongTermDebtTotal, last quarter) + Leases 3.80m
Net Debt = 356.7m CHF (calculated: Debt 505.8m - CCE 149.1m)
Enterprise Value = 2.94b CHF (2.59b + Debt 505.8m - CCE 149.1m)
Interest Coverage Ratio = 9.03 (Ebit TTM 354.8m / Interest Expense TTM 39.3m)
EV/FCF = 14.04x (Enterprise Value 2.94b / FCF TTM 209.6m)
FCF Yield = 7.12% (FCF TTM 209.6m / Enterprise Value 2.94b)
FCF Margin = 7.51% (FCF TTM 209.6m / Revenue TTM 2.79b)
Net Margin = 3.47% (Net Income TTM 97.0m / Revenue TTM 2.79b)
Gross Margin = 41.38% ((Revenue TTM 2.79b - Cost of Revenue TTM 1.64b) / Revenue TTM)
Gross Margin QoQ = 41.88% (prev 40.85%)
Tobins Q-Ratio = 1.48 (Enterprise Value 2.94b / Total Assets 1.99b)
Interest Expense / Debt = 7.77% (Interest Expense 39.3m / Debt 505.8m)
Taxrate = 25.74% (64.2m / 249.4m)
NOPAT = 263.5m (EBIT 354.8m * (1 - 25.74%))
Current Ratio = 1.69 (Total Current Assets 1.21b / Total Current Liabilities 714.1m)
Debt / Equity = 1.49 (Debt 505.8m / totalStockholderEquity, last quarter 340.2m)
Debt / EBITDA = 0.77 (Net Debt 356.7m / EBITDA 464.0m)
Debt / FCF = 1.70 (Net Debt 356.7m / FCF TTM 209.6m)
Total Stockholder Equity = 293.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.66% (Net Income 97.0m / Total Assets 1.99b)
RoE = 33.07% (Net Income TTM 97.0m / Total Stockholder Equity 293.3m)
RoCE = 45.97% (EBIT 354.8m / Capital Employed (Equity 293.3m + L.T.Debt 478.5m))
RoIC = 22.67% (NOPAT 263.5m / Invested Capital 1.16b)
WACC = 8.45% (E(2.59b)/V(3.09b) * Re(8.98%) + D(505.8m)/V(3.09b) * Rd(7.77%) * (1-Tc(0.26)))
Discount Rate = 8.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 85.22 | Cagr: 178.0%
[DCF] Terminal Value 76.14% ; FCFF base≈203.0m ; Y1≈218.3m ; Y5≈265.1m
[DCF] Fair Price = 87.44 (EV 3.99b - Net Debt 356.7m = Equity 3.64b / Shares 41.6m; r=8.45% [WACC]; 5y FCF grow 8.54% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -22.75 | Revenue CAGR: -0.31% | SUE: -0.01 | # QB: 0
EPS current Year (2026-06-30): EPS=3.81 | Chg30d=+4.96% | Revisions=-44% | GrowthEPS=+7.7% | GrowthRev=-2.3%
EPS next Year (2027-06-30): EPS=3.81 | Chg30d=+6.44% | Revisions=+0% | GrowthEPS=+1.8% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: -36% (up=2, down=6)